Contraception Decision Aid Use and Patient Outcomes

Sponsor
Texas Christian University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05177783
Collaborator
(none)
500
1
2
7.5
67

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the impact of a contraception decision aid mobile application on: (a) decisional conflict, (b) reproductive health self-efficacy, (c) contraceptive and reproductive health literacy, and (d) contraceptive use intentions.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Tuune health questionnaire
  • Behavioral: Control health questionnaire
N/A

Detailed Description

After being informed about the study and the potential risks, all participants giving written informed consent will be randomly assigned in a double-blind manner (participant and investigator) in a 1:1 ratio to complete an interactive contraception decision aid health questionnaire (Tuune) or a standard medical questionnaire (Control). After, all participants will be asked questions assessing: (a) decisional conflict, (b) reproductive health self-efficacy, (c) contraceptive and reproductive health literacy, and (d) contraceptive use intentions.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
500 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
ParallelParallel
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description:
Participants will be condition-blind (i.e., they will not be told whether the health application they use is the "treatment" or "control" application). Assignment to treatment arms will be randomized using Qualtrics Experimental Software and treatment assignment group will remain masked to the investigator and those in charge of data analysis until after data analysis is complete.
Primary Purpose:
Supportive Care
Official Title:
Contraception Decision Aid Use and Patient Outcomes
Actual Study Start Date :
Jan 15, 2022
Anticipated Primary Completion Date :
May 30, 2022
Anticipated Study Completion Date :
Aug 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tuune

Participants complete the Tuune contraceptive decision aid health questionnaire.

Behavioral: Tuune health questionnaire
Participants complete the Tuune contraceptive decision aid health questionnaire.

Active Comparator: Control

Participants complete a standard physician intake health questionnaire.

Behavioral: Control health questionnaire
Participants complete a standard physician intake health questionnaire.

Outcome Measures

Primary Outcome Measures

  1. Decisional Conflict [Immediately upon completion of the assigned health questionnaire.]

    Decisional conflict about contraceptive use will be measured using a modified version of the "Traditional Decisional Conflict Scale" to assess decisional conflict about birth control use. The modified version of this scale is a 13-item measure utilizing a 1-7 rating scale (1 = strongly disagree | 7 = strongly agree) asking participants about their decisional conflict with respect to birth control. Higher scores on this scale indicate less decisional conflict about birth control use. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: O'Connor AM (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25-30. doi: 10.1177/0272989X9501500105.

  2. Reproductive Health Self-Efficacy [Immediately upon completion of the assigned health questionnaire.]

    Reproductive health self-efficacy will be measured using a modified version of the "Menstrual Attitudes Questionnaire". The modified version is a 9-item measure utilizing a 1-7 rating scale (1 = strongly disagree | 7 = strongly agree) asking participants about their menstrual cycle and hormonal self-efficacy. Higher scores indicate lower reproductive health self-efficacy. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: Brooks-Gunn, J., & Ruble, D. N. (1980). The Menstrual Attitude Questionnaire. Psychosomatic Medicine, 42(5), 503-512. https://doi.org/10.1097/00006842-198009000-00005

  3. Reproductive Health and Contraceptive Knowledge [Immediately upon completion of the assigned health questionnaire.]

    Reproductive health and contraceptive knowledge will be measured using the following 6-item, 1-7 rating scale (1 = strongly disagree | 7 = strongly agree). Higher scores indicate greater reproductive health and contraceptive knowledge. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/

  4. Contraceptive Use Intentions [Immediately upon completion of the assigned health questionnaire.]

    Contraceptive use intentions will be measured by asking participants to rate their likelihood of using hormonal birth control in the next week, month, and year. Each question will be measured on a 1-7 scale (1 = extremely unlikely to use | 7 = extremely likely to use). Higher scores indicate higher use intentions. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/

Secondary Outcome Measures

  1. Patient Satisfaction [Immediately upon completion of the primary measures.]

    Patient satisfaction with the health questionnaire will be measured using an intervention-tailored version of the "Clinical Use Satisfaction Scale". The modified version is a 14-item measure utilizing two 1-7 rating scales. Items 1 - 12 use the following rating scale: 1 = strongly disagree | 7 = strongly agree. Items 13 - 14 use the scale: 1 = very unlikely | 7 = very likely. Higher scores indicate greater satisfaction with the health questionnaire. A full list of items can be viewed on the Open Science Framework, here: https://osf.io/t4sq2/ References: Zimmerman, M., Gazarian, D., Multach, M., Attiullah, N., Benoff, T., Boerescu, D. A., ... & Holst, C. G. (2017). A clinically useful self-report measure of psychiatric patients' satisfaction with the initial evaluation. Psychiatry research, 252, 38-44.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 34 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Females 18 to 34 years of age who enroll to participate in the study, which will take place on the campus of Texas Christian University.
Exclusion Criteria:
  • Women who are currently pregnant or breastfeeding.

  • Women who wish to become pregnant within the next 12 months.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Texas Christian University Fort Worth Texas United States 76129

Sponsors and Collaborators

  • Texas Christian University

Investigators

  • Principal Investigator: Sarah Hill, PhD, Texas Christian University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sarah Hill, Professor, Texas Christian University
ClinicalTrials.gov Identifier:
NCT05177783
Other Study ID Numbers:
  • TCU020519781
First Posted:
Jan 5, 2022
Last Update Posted:
May 2, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 2, 2022